International Biotechnology Trust plc (IBT) — Working Capital to Net Assets Ratio
International Biotechnology Trust plc (IBT) has a Working Capital to Net Assets ratio of -13.3% as of February 2025. Working capital of GBX-36.46 Million (current assets of GBX5.15 Million minus current liabilities of GBX41.61 Million) is measured against net assets of GBX274.58 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See International Biotechnology Trust plc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
International Biotechnology Trust plc Working Capital to Net Assets (2004–2024)
This chart shows how International Biotechnology Trust plc's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2004 to 2024. As of February 2025, the ratio stands at -13.3%, reflecting working capital of GBX-36.46 Million against net assets of GBX274.58 Million GBX. For the complete balance sheet picture, see total assets of International Biotechnology Trust plc.
Annual Working Capital to Net Assets for International Biotechnology Trust plc (2004–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for International Biotechnology Trust plc from 2004 to 2024, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of International Biotechnology Trust plc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 3.1% | GBX8.78 Million | GBX282.26 Million | GBX10.65 Million | GBX1.87 Million | ▲ +2.2 pp |
| 2023 | 1.0% | GBX2.58 Million | GBX270.32 Million | GBX2.72 Million | GBX143.00K | ▼ -3.3 pp |
| 2022 | 4.3% | GBX12.21 Million | GBX284.89 Million | GBX13.41 Million | GBX1.20 Million | ▲ +4.2 pp |
| 2021 | 0.1% | GBX211.00K | GBX323.77 Million | GBX2.40 Million | GBX2.19 Million | ▼ 0.0 pp |
| 2020 | 0.1% | GBX245.00K | GBX283.90 Million | GBX369.00K | GBX124.00K | ▼ -1.3 pp |
| 2019 | 1.4% | GBX3.40 Million | GBX240.82 Million | GBX3.44 Million | GBX42.00K | ▲ +1.5 pp |
| 2018 | -0.1% | GBX-178.00K | GBX262.47 Million | GBX192.00K | GBX370.00K | ▲ +3.4 pp |
| 2017 | -3.4% | GBX-8.70 Million | GBX252.65 Million | GBX2.90 Million | GBX11.60 Million | ▼ -6.9 pp |
| 2016 | 3.5% | GBX7.49 Million | GBX216.65 Million | GBX9.29 Million | GBX1.79 Million | ▼ -1.8 pp |
| 2015 | 5.3% | GBX12.51 Million | GBX236.00 Million | GBX14.71 Million | GBX2.20 Million | ▲ +8.3 pp |
| 2014 | -3.0% | GBX-6.52 Million | GBX214.97 Million | GBX854.00K | GBX7.38 Million | ▼ -5.5 pp |
| 2013 | 2.4% | GBX4.21 Million | GBX172.67 Million | GBX4.43 Million | GBX224.00K | ▲ +0.4 pp |
| 2012 | 2.1% | GBX2.66 Million | GBX128.92 Million | GBX2.66 Million | GBX8.00K | ▼ -2.2 pp |
| 2011 | 4.2% | GBX3.89 Million | GBX91.76 Million | GBX5.45 Million | GBX1.56 Million | ▲ +3.5 pp |
| 2010 | 0.8% | GBX709.00K | GBX93.66 Million | GBX2.12 Million | GBX1.41 Million | ▲ +0.1 pp |
| 2009 | 0.7% | GBX694.00K | GBX98.25 Million | GBX1.16 Million | GBX464.00K | ▲ +0.6 pp |
| 2007 | 0.1% | GBX67.00K | GBX102.36 Million | GBX1.81 Million | GBX1.75 Million | ▼ -3.0 pp |
| 2006 | 3.1% | GBX2.06 Million | GBX66.95 Million | GBX2.23 Million | GBX167.00K | ▲ +0.2 pp |
| 2005 | 2.9% | GBX1.67 Million | GBX58.00 Million | GBX2.40 Million | GBX731.00K | ▼ -7.8 pp |
| 2004 | 10.7% | GBX5.89 Million | GBX55.15 Million | GBX6.27 Million | GBX378.00K | — |